×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CARM – carisma therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CARM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
08:06 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
12/13
06:32 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
High
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/12
08:07 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $10.00.
Medium
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $10.00.
12/11
12:29 pm
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "in-line" rating re-affirmed by analysts at Evercore ISI. They now have a $0.70 price target on the stock, down previously from $4.00.
Medium
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "in-line" rating re-affirmed by analysts at Evercore ISI. They now have a $0.70 price target on the stock, down previously from $4.00.
12/10
08:08 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
High
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.
12/9
11:17 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its price target lowered by analysts at D. Boral Capital from $24.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its price target lowered by analysts at D. Boral Capital from $24.00 to $12.00. They now have a "buy" rating on the stock.
12/9
08:30 am
carm
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Low
Report
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
11/27
07:30 am
carm
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Low
Report
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Date
Time
Symbol
Company Name
Action
%Chg
8/8/2024
07:30 am
carm
carisma therapeutics, inc.
BEAT
Report
11.2%
carisma therapeutics, inc.
5/9/2024
07:30 am
carm
carisma therapeutics, inc.
MISS
Report
0.7%
carisma therapeutics, inc.
4/1/2024
08:35 am
carm
carisma therapeutics, inc.
BEAT
Report
-12.9%
carisma therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
08:35 am
carm
Form 8-K Carisma Therapeutics For: Dec 07
Low
Report
Form 8-K Carisma Therapeutics For: Dec 07
11/7
07:40 am
carm
Form 10-Q Carisma Therapeutics For: Sep 30
Low
Report
Form 10-Q Carisma Therapeutics For: Sep 30
11/7
07:35 am
carm
Form 8-K Carisma Therapeutics For: Nov 07
Low
Report
Form 8-K Carisma Therapeutics For: Nov 07
11/1
04:31 pm
carm
Form 4 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
Medium
Report
Form 4 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
11/1
04:30 pm
carm
Form 3 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
Medium
Report
Form 3 Carisma Therapeutics For: Oct 31 Filed by: Cheng Sohanya Roshan
10/30
04:31 pm
carm
Form 8-K Carisma Therapeutics For: Oct 24
Low
Report
Form 8-K Carisma Therapeutics For: Oct 24
10/11
04:49 pm
carm
Form 8-K Carisma Therapeutics For: Oct 10
Medium
Report
Form 8-K Carisma Therapeutics For: Oct 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: